The anti-tumor activity observed correlated with elevated levels of number of circulating CD3+ T and activated (Ki67+) CD3+ T cells in the blood 9 day and 13 days after last treatment (Figure 6D-F). The gene discussed is MKI67; the disease is neoplasm.